He learned a great deal about the pharmaceutical business before joining his current organization, with a particular emphasis on the US generic market.
The CEO and director of Divi’s Laboratories Ltd., a generic medication manufacturer, is Dr. Kiran S. Divi. Since January 2020, he has been in his present position. He is in charge of all business affairs and operations at the production plants. He is the managing director of the company and the son of Dr. Murali K. Divi, the richest man in Hyderabad, who created it. With a net worth of USD 9.5 billion, Forbes lists him as one of the nation’s wealthiest pharmaceutical billionaires. As of March 19, the market value of his company was Rs 1.55 lakh crore.
Dr. Kiran Divi joined Divi’s in August 2001. In January 2020, he formally assumed the position of CEO, heading the business. Under his leadership, the organization has been creating excellent business plans and strategies that are in line with both short- and long-term goals. From Mangalore University, he graduated with a bachelor’s degree in pharmacy. Dr. Kiran completed his postgraduate studies at Jawaharlal Nehru Technological University in pharmacy. Additionally, he attended the Gandhi Institute of Technology and Management in Visakhapatnam to pursue a PhD.
He learned a great deal about the pharmaceutical business before joining his father’s business, paying particular attention to the US generic market. Nilima Prasad Divi, her sister, has been a full-time director (commercial) of the business. She joined Divi’s in July of 2012. Both of them assist their father in managing the house.
